Hemophilia A Gene Therapy Placed on Clinical Hold

Pfizer and Sangamo voluntarily paused the trial after participants experienced FVIII activity levels of over 150%.

FasTCAR Cell Therapy Granted Orphan Drug Designation for Multiple Myeloma

The designation follows durable responses seen in a phase 1 study of the agent.

Overcoming Challenges With CAR T Therapies in Solid Tumors: Julian Molina, MD, PhD

The hematologist/oncologist from Mayo Clinic discussed the role of HLA loss in a variety of cancers.